CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 8-K Event Unregistered share sale
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 10-Q/A Report 10-Q/A
- 10-K/A Report 10-K/A
- 8-K Event Results of operations · Restatement
- NT 10-Q Other NT 10-Q
- 8-K Event Auditor change
Page 5 of 31 · 615 filings